Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : SPM-0404
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Preclinical
Sponsor : Sea Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Partnership
Sea Pharmaceuticals Forms Alliance to Advance CNS Disorder Treatments
Details : The partnership aims to advance the clinical development of SPM-0404, which is being evaluated for the treatment of tinnitus, epilepsy.
Product Name : SPM-0404
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 06, 2025
Lead Product(s) : SPM-0404
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Preclinical
Sponsor : Sea Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Partnership